Gregory Verdine

Gregory Verdine

Fortune : 2 M $ au 31/05/2026

66 ans
Health Technology
Finance
Consumer Services

Profil

Gregory L.
Verdine
is the founder of Enanta Pharmaceuticals, Inc. (1995), Rein Therapeutics, Inc. (2001), Tokai Pharmaceuticals, Inc. (2004), Sesen Bio, Inc. (2008), Warp Drive Bio, Inc. (2012), Wave Life Sciences Ltd. (2012), Wave Life Sciences USA, Inc. (2012), Gloucester Marine Genomics Institute (2013), Gloucester Biotechnology Academy (2013), and LifeMine Therapeutics, Inc. (2016).
Titles held at these companies included Independent Director at Enanta Pharmaceuticals, Inc., Director at Rein Therapeutics, Inc., Director at Wave Life Sciences Ltd., Director at Wave Life Sciences USA, Inc., Director at Sesen Bio, Inc., President, Director & Chief Scientific Officer at Warp Drive Bio, Inc., Director at Gloucester Marine Genomics Institute, Director at Gloucester Biotechnology Academy, and President, Chief Executive Officer & Director at LifeMine Therapeutics, Inc. Dr. Verdine is also the founder of Gloucester Pharmaceuticals, Inc...
Current jobs include Professor at Harvard University since 1988, Professor at Harvard Medical School since 1989, and Venture Partner at 6 Dimensions Capital.
Former jobs include Director at Gates Foundation Trust, Director at Dana-Farber Cancer Institute, Inc., Director-Scientific Counsellors at National Cancer Institute, Director-Scientific Counselors at Memorial Sloan Kettering Cancer Center, Principal at Mendel Biotechnology, Inc., Venture Partner at Apple Tree Venture Management LLC from 2003 to 2009, Venture Partner at Third Rock Ventures LLC, and Venture Partner at TPG Biotech.
Education includes undergraduate studies at St. Joseph's University and a doctorate from The Trustees of Columbia University in The City of New York conferred in 1986.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
27/04/2026 252 517 ( 0,13 % ) 2 M $ 31/05/2026

Postes actifs de Gregory Verdine

SociétésPosteDébut
WAVE LIFE SCIENCES LTD. Fondateur 23/07/2012
Corporate Officer/Principal 01/01/1989
Fondateur 01/09/2016
Private Equity Investor -
Fondateur 01/01/2012
Corporate Officer/Principal 22/07/2009

Anciens postes connus de Gregory Verdine

SociétésPosteFin
PARABILIS MEDICINES, INC. Directeur Général 30/06/2023
Fondateur 01/04/2016
Fondateur 01/01/2016
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Gregory Verdine

Formation de Gregory Verdine

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

88

Relations au 1er degré

25

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées25

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Services

Commercial Services

Consumer Services

Health Technology

Miscellaneous

Health Services

Finance

Health Technology

Finance

Consumer Services

Health Technology

Commercial Services

Finance

Utilities

Health Technology

Health Technology

Gloucester Biotechnology Academy

Health Technology

Finance

  1. Bourse
  2. Insiders
  3. Gregory Verdine
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇